Literature DB >> 16239581

Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis.

Melissa M Barousse1, Terri Espinosa, Kathleen Dunlap, Paul L Fidel.   

Abstract

Vaginal epithelial cell (VEC) anti-Candida albicans activity, despite being measured in vitro, is considered an innate host defense mechanism. This was supported further by the fact that women protected from symptomatic infection following a live intravaginal Candida challenge had increased VEC anti-Candida activity compared to those who acquired a symptomatic infection.

Entities:  

Mesh：

Year:  2005        PMID： 16239581      PMCID： PMC1273905          DOI： 10.1128/IAI.73.11.7765-7767.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Growth inhibition of Candida by human oral epithelial cells.

Authors:  C Steele; J Leigh; R Swoboda; P L Fidel
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

Review 2.  History and new insights into host defense against vaginal candidiasis.

Authors:  Paul L Fidel
Journal:  Trends Microbiol       Date:  2004-05       Impact factor: 17.079

3.  Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection.

Authors:  C A Black; F M Eyers; A Russell; M L Dunkley; R L Clancy; K W Beagley
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Vaginal and oral epithelial cell anti-Candida activity.

Authors:  Fatema Nomanbhoy; Chad Steele; Junko Yano; Paul L Fidel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 5.  Pathogenesis and treatment of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

6.  Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.

Authors:  J Yano; E A Lilly; C Steele; D Fortenberry; P L Fidel
Journal:  Oral Microbiol Immunol       Date:  2005-08

7.  Growth inhibition of Candida albicans by human vaginal epithelial cells.

Authors:  M M Barousse; C Steele; K Dunlap; T Espinosa; D Boikov; J D Sobel; P L Fidel
Journal:  J Infect Dis       Date:  2001-12-01       Impact factor: 5.226

Review 8.  Immunopathogenesis of recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

9.  An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Authors:  Paul L Fidel; Melissa Barousse; Terri Espinosa; Mercedes Ficarra; Joy Sturtevant; David H Martin; Alison J Quayle; Kathleen Dunlap
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.

Authors:  M M Barousse; B J Van Der Pol; D Fortenberry; D Orr; P L Fidel
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519
View more
  16 in total

1.  Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.

Authors:  Vyacheslav Abramov; Valentin Khlebnikov; Igor Kosarev; Guldana Bairamova; Raisa Vasilenko; Natalia Suzina; Andrey Machulin; Vadim Sakulin; Natalia Kulikova; Nadezhda Vasilenko; Andrey Karlyshev; Vladimir Uversky; Michael L Chikindas; Vyacheslav Melnikov
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

2.  Genetic basis for recurrent vulvo-vaginal candidiasis.

Authors:  Martin Jaeger; Theo S Plantinga; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 3.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

Review 4.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.

Authors:  Junko Yano; Elizabeth Lilly; Melissa Barousse; Paul L Fidel
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

6.  Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis.

Authors:  Preeti G Dharmik; A V Gomashe; V G Upadhyay
Journal:  J Obstet Gynaecol India       Date:  2012-11-02

7.  Cervical mucins carry alpha(1,2)fucosylated glycans that partly protect from experimental vaginal candidiasis.

Authors:  Steven E Domino; Elizabeth A Hurd; Kristina A Thomsson; David M Karnak; Jessica M Holmén Larsson; Elisabeth Thomsson; Malin Bäckström; Gunnar C Hansson
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

8.  Yeast Infection and Diabetes Mellitus among Pregnant Mother in Malaysia.

Authors:  Iylia Liyana Sopian; Sa'adiah Shahabudin; Mowaffaq Adam Ahmed; Leslie Than Thian Lung; Doblin Sandai
Journal:  Malays J Med Sci       Date:  2016-01

Review 9.  Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".

Authors:  Junko Yano; Brian M Peters; Mairi C Noverr; Paul L Fidel
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

10.  Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans.

Authors:  R Doug Wagner; Shemedia J Johnson
Journal:  J Biomed Sci       Date:  2012-06-20       Impact factor: 8.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.